Cleared Special

K192599 - ASAHI PTCA Guide Wire ASAHI Gaia Next

K192599 is the FDA 510(k) clearance for ASAHI PTCA Guide Wire ASAHI Gaia Next by Asahi Intecc Co., Ltd.. It is a Class 2 Cardiovascular device (product code DQX) cleared through the Special 510(k) pathway after a 104-day FDA review.

K192599 · Asahi Intecc Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2020
Decision
104d
Days
Class 2
Risk

K192599 is an FDA 510(k) clearance for the ASAHI PTCA Guide Wire ASAHI Gaia Next. Classified as Wire, Guide, Catheter (product code DQX), Class II - Special Controls.

Submitted by Asahi Intecc Co., Ltd. (Seto, JP). The FDA issued a Cleared decision on January 2, 2020 after a review of 104 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1330 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Asahi Intecc Co., Ltd. devices

Submission Details

510(k) Number K192599 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 20, 2019
Decision Date January 02, 2020
Days to Decision 104 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
21d faster than avg
Panel avg: 125d · This submission: 104d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DQX Wire, Guide, Catheter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Asahi Intecc USA, Inc.
Cynthia Valenzuela

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DQX Wire, Guide, Catheter

All 499
Devices cleared under the same product code (DQX) and FDA review panel - the closest regulatory comparables to K192599.
Mirage Hydrophilic Guidewire, X-pedion Hydrophilic Guidewire
K193548 · Micro Therapeutics, Inc. d/b/a ev3 Neurovascular · Jan 2020
Wattson Temporary Pacing Guidewire
K192454 · Vascular Solutions · Jan 2020
OptoWire III
K191907 · Opsens, Inc. · Jan 2020
CrossTorq 14 Guidewire
K193194 · Scientia Cardio Access, LLC · Dec 2019
HI-TORQUE InfilTrac Guide Wire Family
K193126 · Abbott Vascular · Dec 2019
Heraeus Peripheral Guidewire
K191502 · Heraeus Medical Components, LLC · Nov 2019